Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Stefania Momi, Michela Tantucci, Maarten Van Roy, Hans Ulrichts, Giovanni Ricci, Paolo Gresele

Blood (2013) 121 (25): 5088–5097.

https://doi.org/10.1182/blood-2012-11-464545

Published: 2013

Includes: Supplemental data

Journal Articles

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

Filip Callewaert, Jan Roodt, Hans Ulrichts, Thomas Stohr, Walter Janse van Rensburg, Seb Lamprecht, Stefaan Rossenu, Sofie Priem, Wouter Willems, Josefin-Beate Holz

Blood (2012) 120 (17): 3603–3610.

https://doi.org/10.1182/blood-2012-04-420943

Published: 2012

Includes: Supplemental data

Journal Articles

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Hans Ulrichts, Karen Silence, Anne Schoolmeester, Peter de Jaegere, Stefaan Rossenu, Jan Roodt, Sofie Priem, Marc Lauwereys, Peter Casteels, Femke Van Bockstaele, Katrien Verschueren, Patrick Stanssens, Judith Baumeister, Josefin-Beate Holz

Blood (2011) 118 (3): 757–765.

https://doi.org/10.1182/blood-2010-11-317859

Published: 2011

Includes: Supplemental data

Journal Articles

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Khalid Abd-Elaziz, Pieter W. Kamphuisen, Christophe Lyssens, Mariska Reuvers, Izaak den Daas, Femke Van Bockstaele, Kristof Vercruysse, Hans Ulrichts, Judith Baumeister, Patricia Crabbe, Veerle Compernolle, Josefin-Beate Holz

Blood (2009) 114 (22): 1063.

https://doi.org/10.1182/blood.V114.22.1063.1063

Published: 2009

Journal Articles

Human Platelet Glycoprotein VI: Identification of Residues Involved in the Binding to Collagen.

Martine Jandrot-Perrus, MD PhD, Christelle Lecut, PhD, Veronique Arocas, PhD, Hans Ulrichts, PhD, Jean-Luc Villeval, PhD, Jean-Jacques Lacapere, PhD, Hans Deckmyn, PhD

Blood (2004) 104 (11): 1550.

https://doi.org/10.1182/blood.V104.11.1550.1550

Published: 2004

Journal Articles

Inhibition of the Shear-Induced Platelet Microparticle Formation by a mAb Against GPIb alpha Is Associated with Protein Tyrosine Dephosphorylation and the Blockade of Filamin Cleavage.

Julio Reséndiz, MD, Luca Pontiggia, PhD, Riitta Lassila, MD, Beat Steiner, PhD, Hans Deckmyn, MD, Hans Ulrichts, MD, Juerg H. Beer, MD.

Blood (2004) 104 (11): 1552.

https://doi.org/10.1182/blood.V104.11.1552.1552

Published: 2004

NARROW

Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Human Platelet Glycoprotein VI: Identification of Residues Involved in the Binding to Collagen.

Inhibition of the Shear-Induced Platelet Microparticle Formation by a mAb Against GPIb alpha Is Associated with Protein Tyrosine Dephosphorylation and the Blockade of Filamin Cleavage.

Email alerts

ASH Publications

American Society of Hematology

Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Human Platelet Glycoprotein VI: Identification of Residues Involved in the Binding to Collagen.

Inhibition of the Shear-Induced Platelet Microparticle Formation by a mAb Against GPIb alpha Is Associated with Protein Tyrosine Dephosphorylation and the Blockade of Filamin Cleavage.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only